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The E2F transcription factor family is known to play a key role in the timely expression of genes required for
cell cycle progression and proliferation, but only a few E2F target genes have been identified. We explored the
possibility that E2F regulators play a broader role by identifying additional genes bound by E2F in living
human cells. A protocol was developed to identify genomic binding sites for DNA-binding factors in
mammalian cells that combines immunoprecipitation of cross-linked protein–DNA complexes with DNA
microarray analysis. Among ∼ 1200 genes expressed during cell cycle entry, we found that the promoters of 127
were bound by the E2F4 transcription factor in primary fibroblasts. A subset of these targets was also bound
by E2F1. Most previously identified target genes known to have roles in DNA replication and cell cycle
control and represented on the microarray were confirmed by this analysis. We also identified a remarkable
cadre of genes with no previous connection to E2F regulation, including genes that encode components of the
DNA damage checkpoint and repair pathways, as well as factors involved in chromatin assembly/
condensation, chromosome segregation, and the mitotic spindle checkpoint. Our data indicate that E2F
directly links cell cycle progression with the coordinate regulation of genes essential for both the synthesis of
DNA as well as its surveillance.
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The E2F transcription factor family plays a crucial and
well-established role in cell cycle progression (Dyson
1998). This family comprises six different polypeptides
(E2F1–E2F6) that pair with a heterodimeric partner (DP1
or DP2). E2F is thought to function by activating a panel
of genes involved in progression through the G1 phase as
well as DNA replication. An important function of E2F
is the recruitment of the retinoblastoma (pRB) tumor
suppressor family of proteins (“pocket” proteins);this
family includes the related proteins p107 and p130 (Har-
bour and Dean 2000). We and others have shown that
E2F-mediated recruitment of pocket proteins in quies-
cent cells and the early G1 phase of the cell cycle results
in repression of genes that are subsequently activated at
the G1/S phase transition. The pRB family both inhibits
transcriptional activation of E2F and globally represses
promoters by recruiting histone deacetylases (HDACs)
(Brehm et al. 1998;Luo et al. 1998;Magnaghi-Jaulin et al.
1998;Ross et al. 1999, 2001).
The E2F family can be functionally subdivided into
repressors (E2F4 and E2F5) and activators (E2F1, E2F2,
and E2F3) based on a number of findings. First, E2F target
gene expression is reduced in E2F3-deficient mouse em-
bryonic fibroblasts, and these cells show significant pro-
liferative defects (Humbert et al. 2000). Chromatin im-
munoprecipitation (ChIP) experiments have shown that
E2F1, E2F2, and E2F3 associate with the promoters of
previously described human and mouse E2F-responsive
genes coincident with their activation at the G1/S phase
boundary (Takahashi et al. 2000;J. Rayman, Y. Takaha-
shi, and B. Dynlacht, unpubl.). Unlike E2F1, E2F2, and
E2F3, which are constitutively nuclear, entry of E2F4
and E2F5 into the nucleus is restricted to cells in G0 and
early G1 and may depend on posttranslational modifica-
tion, association with pRB family members, or het-
erodimerization with DP-2 (Magae et al. 1996;Lindeman
et al. 1997;Muller et al. 1997;Verona et al. 1997). Bind-
ing of E2F4 to promoters in living quiescent cells coin-
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of histones at the promoter, and gene repression (Taka-
hashi et al. 2000). However, it is formally possible that
E2F4 and E2F5 could activate transcription under some
circumstances, because E2F4 has been detected on cer-
tain mouse promoters in late G1/S phase (Wells et al.
2000).
Despite the considerable progress that has been made
toward understanding how E2F and pRB regulate the cell
cycle, it has not been possible until very recently to iden-
tify direct and physiologically relevant downstream tar-
gets of these important cell cycle regulators. Much work
has been focused on elucidating targets of E2F and pRB
by means of transient transfection assays and promoter
analysis. Although these studies have identified a num-
ber of genes that are likely to be E2F regulated, they
suffer from important caveats. First, transfected plas-
mids are not reconstituted into chromatin, a natural sub-
strate for HDAC corepressors believed to be recruited by
the pRB family. Although selective activation of certain
promoters after ectopic expression of individual E2F
family members has been observed in some settings (De-
Gregori et al. 1997), it is often difficult to recapitulate
both target specificity and biologically relevant temporal
regulation under these conditions. Furthermore, overex-
pression of E2F is known to drive cell proliferation, re-
sulting in secondary transcriptional changes linked to
cell cycle status. The recent adaptation of chromatin im-
munoprecipitation approaches to the study of E2F-regu-
lated gene expression (Takahashi et al. 2000) permits an
examination of direct targets of E2F and pRB family
members in living cells at different stages of the cell
cycle without the above caveats.
Identification of the complete set of physiologically
important targets of E2F and other transcription factors
in the human genome would provide a valuable founda-
tion for further understanding of the roles of these fac-
tors in cellular regulation, but there are two important
limitations to experiments that might produce this
knowledge. First, a DNA microarray-based technique
that identifies genomic sites bound directly by DNA-
binding factors has been developed for living yeast cells
(Ren et al. 2000;Iyer et al. 2001;Simon et al. 2001;
Wyrick et al. 2001), but it is not clear that this method
will produce significant signal-to-noise ratios with the
more complex mammalian genome. Second, the se-
quence of the human genome is incomplete, making it
impossible to produce a DNA microarray that represents
all promoter sites. We describe here solutions to these
two issues that allowed us to identify a large number of
new E2F target genes that are cell cycle-regulated. We
report modifications of the yeast factor location tech-
nique that allow robust identification of promoters in
living human cells that are bound by specific transcrip-
tion factors. We focused our studies on E2F and the
proximal promoters of nearly 1200 human genes whose
expression is cell cycle-dependent by producing a micro-
array with these promoter sequences. Our results indi-
cate that E2F plays a heretofore unrecognized role in the
regulation of genes required for DNA repair, chromatin
assembly, condensation, and segregation, as well as mul-
tiple checkpoints that ensure genomic integrity. There-
fore, E2F does not exclusively regulate genes important
for the G1/S transition. Rather, E2F plays a role in the
expression of genes involved in multiple cell cycle con-
trol points.
Results
Mammalian factor location analysis
We first examined the occupancy of E2F4 on promoters
during quiescence, since previous ChIP experiments
have indicated that E2F4 directs recruitment of the pRB-
related protein p130 to repress several genes during cell
cycle exit (Takahashi et al. 2000). Primary human fibro-
blasts (WI-38) rendered quiescent through serum starva-
tion were fixed with formaldehyde, harvested, and dis-
rupted by sonication (Fig. 1A). To enrich for target genes
bound by E2F, we immunoprecipitated the resulting
chromatin fragments with antibodies that specifically
recognize E2F4. At this point, we made several impor-
tant modifications to protocols previously developed for
yeast genome-wide location analysis (Ren et al. 2000) to
compensate for the increased complexity of the human
genome (see Materials and Methods). After reversal of
cross links, the purified and enriched DNA was ampli-
fied by ligation-mediated polymerase chain reaction
(LM-PCR) and subsequently labeled with the Cy5 fluo-
rophore by random priming. For purposes of normaliza-
tion, we also performed LM-PCR on DNA that was not
enriched by immunoprecipitation and labeled the ampli-
fied sample with a second fluorescent dye, Cy3. ChIP-
enriched and nonenriched (total input) pools of DNA
were mixed with Cot-1 DNA to suppress annealing of
repetitive sequences and hybridized under stringent con-
ditions to a single DNA microarray composed of human
promoters described below.
It is not feasible to conduct a genome-wide microarray
analysis of the location of DNA-binding proteins on hu-
man promoters because the human genome is not yet
fully sequenced. Nevertheless, as an initial effort toward
this ultimate goal, we developed a DNA microarray
(henceforth referred to as the 1.5K array) that contained
polymerase chain reaction (PCR) products spanning the
proximal promoters of 1444 human genes, ∼ 1200 of
which show regulated expression during cell cycle reen-
try (Iyer et al. 1999;Ishida et al. 2001). We included ∼ 200
genes with no apparent link to the cell cycle. Based on
algorithms that predict DNA-binding motifs within pro-
moters (Fig. 1B), we chose as end points of each PCR
reaction regions ∼ 700 bp upstream and 200 bp down-
stream of putative transcription start sites. Known E2F
sites are generally located within 200 nucleotides of the
start site.
The results of two independent E2F4 location analysis
experiments are shown in Figure 2A. The analysis indi-
cates that E2F4 is associated with the promoters of 127
genes based on a P-value  0.002 in the error model (see
Materials and Methods). Several lines of evidence indi-
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tifying factor-binding sites in mammalian cells. First,
the fold-enrichment was at least as good as that observed
in analogous experiments with yeast, where conven-
tional approaches to identify direct factor-binding sites
confirmed essentially all of the microarray results (Ren
et al. 2000). Second, we observed striking enrichment of
a majority of previously reported E2F-responsive promot-
ers, including a number involved in cell cycle control
(p107, pRB, cdc2, cdc25A, cyclin A, E2F2, and E2F3) and
DNA replication (DNA polymerase , cdc6, PCNA, and
thymidine kinase). Indeed, we identified 17 of 20 previ-
ously established E2F targets that were printed on the
microarray (see Discussion). Third, as described below,
all of the target promoters selected for further study were
confirmed to be bound by E2F using conventional ChIP.
The strong enrichment of known E2F-responsive
genes, coupled with the observation that only a small
percentage of the genes regulated during cell cycle pro-
gression were enriched, attests to the highly selective
nature of our ChIP and microarray protocols. Neverthe-
less, we used standard ChIPs to confirm our findings
Figure 1. Strategy for mammalian factor location analysis us-
ing the 1.5K DNA microarray. (A) An illustration of the experi-
mental protocol. Modifications to previous yeast protocols (Ren
et al. 2000) are indicated in red. Primary human cells (WI-38)
were cross-linked and sonicated, and chromatin was immuno-
precipitated with anti-E2F antibodies. The resulting ChIP-en-
riched DNA was purified, amplified by LM-PCR together with
total genomic DNA, labeled with the Cy5 and Cy3 fluorophores
using random priming, and hybridized to the 1.5K microarray in
the presence of Cot-1 DNA to reduce nonspecific hybridization.
(B) The frequency and distribution of transcription factors bind-
ing to human promoters. The distance of transcription factor-
binding sites relative to the transcription start site is plotted
versus the frequency of its occurrence. Most known transcrip-
tion factor binding sites cluster between 200 nucleotides up-
stream and downstream of the start site (data source: http://
transfac.gbf.de/TRANSFAC/).
Figure 2. Location analysis of E2F4 on human promoters and
identification of previously known E2F target genes. (A) Scatter
plot analysis of Cy3-labeled total genomic DNA versus Cy5-
labeled, E2F4 ChIP-enriched DNA. A P-value cutoff of 0.01 is
shown. (B) Confirmation of promoter occupancy by E2Fs in qui-
escent WI-38 cells using a standard ChIPs protocol. E2Fs were
enriched at several promoters involved in cell cycle control and
DNA replication. In contrast, we did not detect enrichment of a
negative control -interferon fragment with anti-E2F4 antibod-
ies. Nor did we observe significant promoter enrichment with
an irrelevant antibody control (mock) lanes. Input lanes corre-
spond to PCR reactions with 0.5% of total chromatin in immu-
noprecipitation reactions.
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pected from previous studies (Takahashi et al. 2000), we
observed significant binding by E2F to the p107 and
cdc25A promoters (Fig. 2B). We extended these findings
by showing that two genes involved in replication,
MCM5 and MCM6, were also occupied by E2F. In con-
trast, we observed no enrichment of unrelated control
genes -interferon and actin (Fig. 2B;data not shown).
E2F4 target genes cluster into seven functional
categories
In addition to previously identified DNA replication and
cell cycle regulatory genes, the genomic location analy-
sis revealed a substantial number of novel E2F targets
(Fig. 3). The E2F4 gene targets that we have identified
clustered into seven functional groups related to cell
cycle regulation, DNA replication, DNA repair, DNA
damage and G2/M checkpoints, chromosome transac-
tions, and mitotic regulation (Fig. 3). Several genes could
be clustered into multiple categories as indicated. Each
of the clusters showed, on average, similar levels of en-
richment (Fig. 3). Interestingly, several genes identified
in the screen encode proteins that are not only function-
ally related but also interact with one another in multi-
meric complexes, suggesting that components of the
DNA damage repair and checkpoint responses are tran-
scriptionally coregulated (see Discussion). Therefore, we
conclude that E2F regulates an array of genes that func-
tion during, and subsequent to, the G1-to-S phase tran-
sition.
E2F1 and E2F4 bind an overlapping set of target genes
We have thus far shown that E2F4 binds a set of target
genes with a high degree of specificity in quiescent cells.
Given that E2F1 appears to associate in vivo with active
promoters during the G1-to-S transition (Takahashi et al.
2000), we examined the binding of E2F1 at promoters of
cells entering S phase. Quiescent WI-38 cells were
stimulated by serum addition, and we confirmed by flow
cytometry (FACS) that a substantial fraction of cells had
entered S phase 26 h after serum addition (data not
shown). G1/S phase samples were cross-linked, and chro-
matin immunoprecipitations were performed with anti-
E2F1 antibodies. ChIP-enriched DNA was then hybrid-
ized to the 1.5K microarray. Interestingly, we observed
significant overlap (50 genes) between the set of genes
bound by E2F4 in quiescent cells and the targets bound
by E2F1 in G1/S phase (Fig. 3). Although E2F1 was found
to be associated with genes involved in mitosis, the vast
majority of targets clustered in the DNA replication and
repair categories.
In order to link our findings on E2F location to gene
regulation, we performed a gene expression profiling ex-
periment to determine when each of the E2F target genes
we identified was induced during cell cycle reentry. Qui-
escent WI-38 cells were stimulated with serum, and
RNA was prepared from nonstimulated cells and those
collected 12, 16, and 26 h poststimulation, correspond-
ing to G1,G 1/S, and S/G2 phase populations. Target
cRNA was prepared and hybridized to Affymetrix high-
density DNA microarrays that contained most of the
genes represented on our 1.5K array. The results are pre-
sented in Figure 3 and are largely consistent with data
obtained from murine and human fibroblasts (Iyer et al.
1999;Ishida et al. 2001). As expected, most of the DNA
replication genes were induced in late G1/S phase. Inter-
estingly, many of the DNA repair, checkpoint, and mi-
totic genes were also induced in late G1 and S phase,
suggesting that E2F could link expression of DNA repli-
cation and repair genes and play a role in the activation
of genes required not only during S phase but at subse-
quent stages of the cell cycle (see Discussion).
These findings are consistent with our previous data
indicating that many E2F-responsive genes are collabo-
ratively regulated by E2F1 and E2F4 at different stages of
the cell cycle (Takahashi et al. 2000). Furthermore, the
widespread overlap in targets enriched by both factors
again points to the high degree of specificity achieved in
our ChIP and microarray experiments.
Confirmation of novel target genes
The genome location experiment revealed a large num-
ber of previously unidentified E2F target genes. It was
therefore important to confirm promoter occupancy by
E2F family members on a subset of genes identified in
our microarray analysis using conventional ChIP analy-
sis (Fig. 4). We observed striking enrichment of E2F4 on
each of the genes we examined in quiescent WI-38 cells.
Interestingly, several DNA repair genes (rad54, bard1),
as well as G2 and mitotic checkpoint genes (chk1, mad2)
were highly enriched with E2F4 antibodies;the enrich-
ment was comparable to, or exceeded, that observed
with the previously characterized cell cycle regulators,
p107 and cdc25A (Fig. 2B;Takahashi et al. 2000). We did
not observe significant promoter enrichment in ChIPs
with irrelevant antibodies (“mock” lanes), nor was en-
richment observed after amplification of unrelated pro-
moter fragments immunoprecipitated with anti-E2F an-
tibodies (data not shown). As for other mammalian cell
cycle synchronization techniques, it is not feasible to
obtain a homogeneous population of quiescent WI-38
cells, and the presence of residual cycling cells results in
the detection of E2F1 (and E2F3) at this stage.
The observed connection between E2F and a signifi-
cant number of DNA repair genes as well as genes in-
volved in the DNA damage and spindle checkpoints was
unexpected. We focused on these promoters and exam-
ined the nucleotide sequence of the amplified products
printed on our microarray for consensus E2F-binding
sites (TTTC/GC/GCGC). Interestingly, inspection of
these promoters revealed the existence of multiple E2F-
binding sites in many of the target genes (data not
shown). However, several promoters lacked obvious E2F
recognition motifs, suggesting either that E2F may rec-
ognize noncanonical binding sites or that in some set-
tings, it may be recruited to the promoter through asso-
Ren et al.
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GENES & DEVELOPMENT 249Figure 3. Identification of E2F1- and E2F4-binding sites in human promoters and functional clustering of target genes. Each of the
clusters is indicated, and previously identified E2F-responsive genes are indicated with bold type. In some cases, genes clustered into
two or more functional categories. For each gene, P-values and average enrichment ratios for E2F4 and E2F1 binding are shown. Binding
ratios are also shown using a blue-and-white color scheme. Those genes bound by both factors are indicated. The final column
illustrates the cell cycle phase during which the indicated genes are induced. Data were obtained using Affymetrix microarray analysis
(see Materials and Methods). In most cases, these expression profiles were also confirmed either by Iyer et al. 1999 (superscript 1),
Ishida et al. 2001 (superscript 2), or both. (nd) Not determined;(G1
−) repression in G1.
250 GENES & DEVELOPMENTciation with other factors. Indeed, it is possible that spe-
cific temporal expression profiles of E2F-responsive
genes could result from combinatorial interactions with
other proximal transcription factors in a manner similar
to the control of certain developmental programs in
yeast (Madhani and Fink 1997). A mutational analysis of
individual promoters will ultimately be required to de-
termine the contribution of E2F-binding sites and proxi-
mal promoter elements to the expression of each gene.
Multiple E2F4 targets are deregulated in the absence
of p107 and p130
Our studies identified novel genes that are bound by
E2F4. Because E2F4 functions as a transcriptional repres-
sor in quiescent and early G1 cells when bound to the
pRB-related proteins p107 and p130, we predict that loss
of these proteins would result in derepression of some or
all of our newly identified E2F4 target genes. We tested
this idea by synchronizing wild-type and p107
−/−; p130
−/−
mouse embryonic fibroblasts (MEFs) by serum starvation
and restimulation and then harvesting cells at various
points after restimulation. We isolated RNA and as-
sessed the level of each transcript by reverse transcrip-
tion coupled with the polymerase chain reaction (RT-
PCR) (Fig. 5). The results confirmed that one well-estab-
lished target of this repressor, cyclin A2, was indeed
derepressed in p107
−/−; p130
−/− MEFs relative to wild-
type cells (Hurford et al. 1997). In contrast, cyclin E ex-
pression was not altered in the mutant cells, again con-
Figure 4. Conventional ChIP analysis confirms the enrichment of genes identified in the 1.5K microarray screen. ChIP was performed
with chromatin from quiescent WI-38 cells using the indicated antibodies, and enriched DNA was amplified with primers corre-
sponding to representative genes from several different clusters.
Figure 5. Novel E2F targets identified in this study are derepressed in mouse embryonic fibroblasts (MEFs) lacking p107 and p130.
Wild-type and p107
−/−; p130
−/− MEFs made quiescent by serum deprivation (t = 0 h) were stimulated to reenter the cell cycle. Cells
were harvested at various times after restimulation, as indicated, and RNA was isolated. Cells entered S phase at the 20-h time point.
RT-PCR analysis was performed using primers corresponding to selected DNA repair, checkpoint control, and mitotic genes as shown.
Cyclin A and actin serve as positive and negative controls for cell cycle synchronization and RNA normalization, respectively.
E2F regulates multiple checkpoints
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when combined with our FACS analysis, also confirms
that these cells were synchronized effectively (data not
shown). Importantly, transcription of a control gene, ac-
tin, was not affected by loss of p107 and p130.
We then compared transcript levels in both wild-type
and mutant MEFs for a subset of the genes identified in
our location analysis. We examined genes involved in
DNA repair, mitotic and DNA damage checkpoints, and
mitosis. Remarkably, we found that loss of p107 and
p130 led to dramatic derepression in G0/G1 of each of the
E2F4 targets that we identified, although the degree of
derepression varied from one gene to another. The DNA
repair gene RAD54L, mitotic checkpoint genes MAD2L
and TTK, and the HEC and NEK2 mitotic genes were
among the most significantly derepressed. These genes
were deregulated to at least the same degree as cyclin A2,
a known target of the E2F4 transcription factor. We con-
clude that these genes, first identified by our location
analysis and surveyed in this assay, are bona fide targets
of the E2F4–p107/p130 transcriptional repressor.
Discussion
Our understanding of the functions of sequence-specific
transcriptional regulators is limited in part by our
knowledge of their target genes. We developed a robust
protocol to identify genomic binding sites for DNA-bind-
ing factors in mammalian cells that combines immuno-
precipitation of cross-linked protein–DNA complexes
with DNA microarray analysis of promoters for genes
that are cell cycle-regulated. This method was used to
identify novel E2F target promoters, which we verified
using two independent assays. Our results indicate that
E2Fs are involved in regulating genes that encode com-
ponents of the DNA damage checkpoint and repair path-
ways, as well as factors involved in chromatin assembly/
condensation, chromosome segregation, and the mitotic
spindle checkpoint.
Previous experiments have identified E2F targets by
profiling genes activated and repressed in response to
ectopic expression of E2F1, E2F2, and E2F3 (Ishida et al.
2001;Kalma et al. 2001;Muller et al. 2001). However,
two potential limitations of such experiments are intro-
duced by this approach. First, there is the potential for
loss of target specificity resulting from overexpression.
Second, this type of experiment does not permit a
straightforward or unequivocal identification of direct
targets, as secondary changes in gene expression result-
ing from progression through the cell cycle are possible
(Ishida et al. 2001). In contrast, the direct binding experi-
ments described here circumvent both complications
and allow for the identification of promoters that are
bound directly by E2F in primary cells under physiologi-
cal conditions.
The binding of a transcriptional activator to the pro-
moter region of a gene suggests that the activator has a
regulatory effect on the gene, but it is also possible that
the activator does not fully or even partially control the
gene. For this reason, we have identified the set of genes
where factor binding correlates with gene expression, an
approach that produced highly accurate information on
transcription factor function in previous studies with
other factors (Ren et al. 2000). We have also confirmed
the importance of E2F binding to several of the novel
targets identified here by examining gene expression in
cells that lack the p107 and p130 repressors recruited by
E2F4. We found that expression of each of these targets
was significantly deregulated in cells lacking p107 and
p130. These findings confirm the functional relevance of
E2F binding in vivo to targets identified in our location
analysis.
Classification of E2F targets
Using a novel DNA microarray that allows us to monitor
promoter binding for a majority of human genes whose
expression is known to oscillate with the cell cycle, we
have identified a large number of putative E2F-respon-
sive genes. A substantial number of these E2F target
genes have not been previously linked to E2F function.
Several important conclusions can be drawn from this
work based on the functional clustering of the E2F tar-
gets we have identified.
Cell cycle regulation We identified eight genes with a
well-established role in cell cycle control. This cluster
includes cyclin A, Cdc2, Cdc25A, CDK2, two members
of the E2F family (E2F2 and E2F3), and two members of
the RB family (RB and p107). Each of these genes had
been regarded as E2F-responsive, and our work confirms
that they are, indeed, direct, physiological targets of E2F.
DNA replication A role for E2F in the activation of
several DNA replication genes has been well established.
Known E2F targets include genes encoding proteins in-
volved in the initiation of replication (Orc1, Mcm pro-
teins, Cdc6), nucleotide metabolism (thymidine kinase),
and the enzymatic synthesis of DNA (DNA polymerase
). Our studies have expanded this list to include addi-
tional nucleotide synthesis and replication factor genes.
These results are consistent with the work of Nevins and
colleagues and others (Ishida et al. 2001;Kalma et al.
2001), who recently identified by expression-profiling sev-
eral of the genes we have isolated as direct targets of E2F.
Mitosis and mitotic spindle checkpoint Previous work
over the past decade had established a primary role for
E2F in regulating the G1/S phase transition, and it is now
clear that cyclins important for this transition and a co-
hort of replication factors and enzymes are physiological
targets of E2F. However, an emerging idea from recent
studies suggests that E2F may be required to regulate
cyclin gene expression beyond S phase (Lukas et al.
1999), and expression-profiling identified several poten-
tial downstream targets involved in mitosis (Ishida et al.
2001). However, given the caveats associated with this
type of experiment described above, it was not possible
to distinguish direct from indirect targets. We identified
a significant number of genes that function in mitosis.
Ren et al.
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tokinesis (Plk, PRC1), chromosome condensation
(SMC4, SMC2), and chromosome segregation (securin or
PTTG1, CENP-E, HEC1). Our experiments strongly sug-
gest that E2F plays a direct role in regulating several
genes involved in mitosis. It is interesting to note that
we have also identified several components of the mi-
totic spindle checkpoint, including CENP-E, Bub3, and
Mad2, proteins that interact with Bub1, which was iden-
tified as an E2F target by Nevins and colleagues (Ishida et
al. 2001). Thus, our work establishes that E2F directly
binds the promoters of genes linked to post-S-phase
events and suggests that it plays an important role in
their expression.
DNA repair Interestingly, we identified a large cluster
of 12 genes required for DNA repair. These genes are
involved in the full spectrum of repair processes, includ-
ing mismatch repair (MSH2, MLH1), base excision repair
(UNG), nucleotide excision repair (RPA3), homologous
recombination (RAD51 and RAD54), and nonhomolo-
gous end-joining (DNA-dependent protein kinase). These
experiments may point to the conservation of a phenom-
enon first noted in Saccharomyces cerevisiae, namely,
that genes involved in repair of DNA damage may be
required during replication to ensure genomic integrity
(Myung et al. 2001). Many of the genes isolated in this
screen are members of multimeric complexes, and our
data suggest that they may be coordinately regulated. For
example, FEN1–PCNA, Rad51–Rad54, Msh2–Mlh1, and
Bard1–Cstf1 interactions have been reported, and several
pairs of interacting proteins were found among the other
functional categories as well. Many of these genes appear
to be bound by E2F4 in quiescent cells when each is
inactive and by the E2F1 activator in G1/S phase cells
when each is expressed (Fig. 3). Furthermore, our analy-
sis of wild-type and p107
−/−; p130
−/− MEFs indicates that
at least two of these genes (RAD54L and BARD1) are
repressed in vivo by these pRB-related proteins during G0
and early G1 (Fig. 5). Consistent with our findings, mu-
rine Rad51 was induced severalfold in cells ectopically
expressing E2F1 or E2F2 (Ishida et al. 2001). Therefore,
our findings link the processes of DNA replication and
repair in mammalian cells and suggest that their expres-
sion could be regulated through a common factor, E2F.
Checkpoint controls One of our most surprising find-
ings was the identification of a cluster of genes involved
in several different checkpoints. We identified two genes
involved in the DNA damage checkpoint, p53 and Chk1.
p53 is induced in response to DNA damage and acts to
enforce a cell cycle block in G1 phase (Zhou and Elledge
2000). The identification of p53 as an E2F target was
unanticipated, because the p53 promoter lacks a recog-
nizable E2F consensus site (data not shown). This finding
may be explained by the indirect recruitment of E2F by
additional promoter-bound factors. E2F has been shown
previously to indirectly increase levels of p53 through
activation of the p14
ARF gene, a component of the
p14
ARF–Mdm2 stabilization pathway (DeGregori et al.
1997;Bates et al. 1998;Robertson and Jones 1998). Our
results suggest that E2F may also directly control p53
expression levels. This finding is also intriguing in light
of previous reports implicating an essential role for both
p53 and the pRB family in the G1 DNA damage arrest
checkpoint (Harrington et al. 1998;Dannenberg et al.
2000;Sage et al. 2000). The mechanisms underlying the
pRB requirement for this G1 block are not known, al-
though a role for E2F-responsive genes has been postu-
lated (Harrington et al. 1998). A second checkpoint gene,
Chk1, was also identified in our E2F location analysis.
CHK1 is required for the G2 DNA damage (and perhaps
an S phase) checkpoint (Zhou and Elledge 2000). Inter-
estingly, pRB was required for Chk1 down-regulation
and resumption of G2 after DNA damage, suggesting
that E2F could be involved in Chk1 gene expression
(Gottifredi et al. 2001).
We also identified several components of the mitotic
spindle checkpoint, including CENP-E, Bub3, Mad2, and
the TTK kinase (a homolog of yeast Mps1p). These pro-
teins have been shown to interact, again suggesting that
this checkpoint may be controlled coordinately by E2F.
Interestingly, we found that two of these genes, MAD2L
and TTK, as well as several mitotic genes (HEC, NEK2,
and PTTG1), were significantly derepressed in quiescent
and early G1 cells deficient for the E2F4–p107/p130 re-
pressor.
Taken together with expression-profiling experiments
and our analysis of wild-type and mutant MEFs, the
above clustering suggests that the DNA damage-re-
sponse and checkpoint controls may be entrained to the
cell cycle through E2F regulation (Fig. 6). That is, each of
these repair and checkpoint genes is inactive in cells that
have exited the cell cycle and have no immediate need
for repair. This inactive state correlates with binding by
E2F4. This idea appears to be consistent with recent
studies in mouse cells in which it was shown that pro-
liferation was required for repair of mutations (Bielas and
Heddle 2000). However, as cells reenter the cell cycle
and approach S phase, it is necessary to activate genes
needed for repair of the DNA damage that occurs during
replication. This period coincides with the time at which
E2F is expressed and bound in vivo to genes involved in
the DNA replication and repair pathways.
Recent gene expression-profiling experiments had also
identified a number of genes involved in apoptosis, sig-
naling, and differentiation (Muller et al. 2001). Despite
the fact that promoter fragments for a subset of these
genes were represented on our cell cycle microarray, it is
worth noting that these genes were not identified in our
microarray screen. The basis for this discrepancy is un-
known at present, although divergent experimental pro-
tocols, including the use of different cell lines and ecto-
pic versus endogenous expression of E2Fs, might account
for the variance.
Conclusions
We and others showed previously that several genes are
regulated by multiple E2F family members (Takahashi et
E2F regulates multiple checkpoints
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us to discriminate between opposing transcriptional sig-
nals: E2F4 is recruited to promoters repressed in quies-
cent cells, whereas E2F1 and E2F3 are enriched at pro-
moters activated during the G1-to-S phase transition.
This strongly suggests that the E2F family can be
grouped into activator (E2F1, E2F2, and E2F3) and repres-
sor (E2F4 and E2F5) subclasses. The microarray approach
described here, in combination with gene expression-
profiling experiments, will allow us to extend these find-
ings on a much larger scale. Furthermore, the robust
method we have developed to identify genomic binding
sites for DNA-binding factors in mammalian cells will
be a powerful tool for identifying the genomic loci that
are directly regulated by most DNA-associated proteins,
including those involved in gene expression and chromo-
somal maintenance. Such studies in yeast have begun to
reveal the transcriptional networks that regulate the cell
cycle and the response to nutrients (Ren et al. 2000;Iyer
et al. 2001;Simon et al. 2001) and have identified origins
of DNA replication throughout the genome (Wyrick et
al. 2001). Similar studies can now be envisioned in mam-
malian cells.
Cancer cells are frequently unable to arrest in G1 in
response to DNA-damaging agents (for review, see Zhou
and Elledge 2000). Knowledge of the location of key tran-
scription factors on their immediate downstream targets
induced by DNA damage may suggest new therapeutic
strategies. Indeed, our screen has revealed the direct
binding by E2F to several tumor suppressors and other
genes whose mutation results in genomic instability and
cancer, including securin, mitotic checkpoint genes, and
mismatch repair genes (Fishel et al. 1993;Cahill et al.
1998;Jallepalli et al. 2001). A more complete under-
standing of the targets of cell cycle regulators throughout
the human genome will be an important goal for future
studies.
Materials and methods
Cell culture
Primary human WI-38 cells were obtained from ATCC. Cells
were grown in DMEM containing 10% fetal bovine serum (FBS)
and were made quiescent by removal of serum for 3 d. Where
indicated, cells were stimulated to enter the cell cycle by adding
10% FBS to the medium. Cell cycle position was monitored by
propidium iodide staining and flow cytometry.
1.5K and Affymetrix DNA microarrays
Approximately 900 nucleotide fragments were amplified by
PCR from human genomic DNA based on previous cell cycle
gene expression-profiling data (Iyer et al. 1999;Ishida et al.
2001). Primer sequences are available upon request, and the
identity and sequence for all genes on the 1.5K array are avail-
able as Supplemental Data (http://www.genesdev.org). Target
Figure 6. Model illustrating the pervasive role of E2F in several phases of the cell cycle and in multiple checkpoints. The bold
horizontal line denotes the cell cycle. In addition to regulating several cell cycle regulatory genes, including those encoding cyclins,
CDKs, other E2Fs, and the pRB family, E2F4 is bound to genes involved in the G1 and G2 DNA damage checkpoints, DNA replication,
and DNA repair. E2F4 also binds to genes that function to promote chromosome condensation and segregation as well as the spindle
checkpoint. Although E2F1 bound several genes involved in mitosis, most genes bound by this transcription factor in our location
analysis clustered in the DNA replication and repair pathways.
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to U95A microarrays were carried out according to the manu-
facturer’s instructions. For the Affymetrix experiments, we
identified an induced gene as one that was enhanced 2.5-fold
relative to 0 h for two consecutive time points.
Amplification, labeling, and hybridization of DNA to 1.5K
DNA microarray
The immunoprecipitated (ChIP) DNA and 1/200 of total input
DNA were amplified in parallel according to a ligation-medi-
ated PCR protocol (Ren et al. 2000), with the following modifi-
cations: (1) After ligation to universal linkers, the DNA was
amplified in 25 cycles of PCR, without the addition of fluores-
cence-labeled dUTP. (2) After PCR, the DNA was first purified
with the use of QIAQuick PCR purification kit (QIAGEN).
After amplification, one-half of the resulting DNA was used
as template for random priming reactions in the presence of 3
µL of either Cy5-dUTP (Amersham Pharmacia) or Cy3-dUTP
(Amersham Pharmacia) with the use of a BioPrime DNA label-
ing kit (Invitrogen). The Cy5-labeled DNA that was prepared
from the immunoprecipitated chromatin sample was combined
with Cy3-labeled DNA corresponding to the total input DNA
and was then hybridized to a 1.5K DNA microarray chip accord-
ing to Ren et al. (2000), with modification of the hybridization
condition. Each hybridization reaction included the Cy5- and
Cy3-labeled DNA, 20 µg of human Cot-1 DNA enriched for
repetitive DNA sequences such as the Alu and Kpn family
members (Invitrogen), 40 µg of yeast tRNA (Sigma), 2.2× SSC,
0.1% SDS, 0.12% BSA (Sigma), 28% formamide (Sigma), and
5.7% dextran sulfate (Sigma), in a total of 50 µL. The hybrid-
ization was carried out in microarrray hybridization chambers
(Corning) and incubated at 60°C for 16 h. The microarrays were
then washed according to Ren et al. (2000) and scanned with the
use of ScanArray5000 scanner (Packard). Detailed protocols are
available upon request.
Microarray data analysis
Analysis of microarray scanning images was performed accord-
ing to Ren et al. (2000). An error model was used to quantify the
enrichment of each DNA species by immunoprecipitation. A
probability value (P-value) was calculated to indicate the sig-
nificance of enrichment for each DNA species on the array.
Data from independent replicate experiments were combined
according to Ren et al. (2000). An average enrichment ratio was
calculated for each DNA species on the array from 4–6 replicate
data sets. The binding of a factor to DNA is deemed significant
if the averaged P-value is <0.002. Using these criteria, no DNA
was judged significant in control experiments where input DNA
was compared to the same DNA.
Standard chromatin immunoprecipitation
Chromatin immunoprecipitations were performed essentially
as described previously (Takahashi et al. 2000), except that the
cesium chloride purification step was omitted. Antibodies
against E2F1 (sc-193) and E2F4 (sc-1082) were obtained from
Santa Cruz. The sequence of primers used to amplify ChIP-
enriched DNA is available upon request.
RT-PCR
Mouse embryonic fibroblasts (kind gift of J. Dannenberg and H.
te Riele, Netherlands Cancer Institute) were rendered quiescent
by starvation for 3 d with DMEM-lacking serum. Cells were
stimulated to reenter the cell cycle with the addition of 20%
FBS, harvested at various times, and RNA was extracted using
Trizol reagent. RT-PCR was performed using Invitrogen RT-
PCR Superscript One Step kit as described by the manufacturer.
Primer sequences are available upon request. We ensured linear
amplification in all cases, and reactions were performed a mini-
mum of two, but most often three, times.
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